Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Cash from Financing Activities (2016 - 2025)

Bruker (BRKR) has disclosed Cash from Financing Activities for 16 consecutive years, with -$167.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 123.47% year-over-year to -$167.6 million, compared with a TTM value of $135.1 million through Dec 2025, down 89.01%, and an annual FY2025 reading of $135.1 million, down 89.01% over the prior year.
  • Cash from Financing Activities was -$167.6 million for Q4 2025 at Bruker, down from $258.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.2 billion in Q2 2024 and bottomed at -$217.4 million in Q1 2022.
  • Average Cash from Financing Activities over 5 years is $53.7 million, with a median of -$37.1 million recorded in 2021.
  • The sharpest move saw Cash from Financing Activities plummeted 3053.85% in 2022, then surged 11321.36% in 2024.
  • Year by year, Cash from Financing Activities stood at $404.3 million in 2021, then tumbled by 108.93% to -$36.1 million in 2022, then plummeted by 65.93% to -$59.9 million in 2023, then dropped by 25.21% to -$75.0 million in 2024, then plummeted by 123.47% to -$167.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for BRKR at -$167.6 million in Q4 2025, $258.4 million in Q3 2025, and $95.5 million in Q2 2025.